Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Woodward
WWD
$23B
| $2.45M | ﹤0.01% |
53,804
-294,273
| -85% | -$12.3M |
|
|
TRAK
552
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $2.43M | ﹤0.01% |
50,514
-67,816
| -57% | -$2.82M |
|
553
iShares Core S&P 500 ETF
IVV
$858B
| $2.31M | ﹤0.01% |
12,416
+2,112
| +20% | +$376K |
|
554
Nordson
NDSN
$16.4B
| $2.27M | ﹤0.01% |
30,550
-8,047
| -21% | -$586K |
|
|
BCOV
555
DELISTED
Brightcove, Inc.
BCOV
| $2.23M | ﹤0.01% |
157,899
-3,173
| -2% | -$44.3K |
|
|
XLRN
556
DELISTED
Acceleron Pharma
XLRN
| $2.19M | ﹤0.01% |
+55,366
| New | +$1.34M |
|
|
SFG
557
DELISTED
STANCORP FINL GRP
SFG
| $2.12M | ﹤0.01% |
31,954
-40,199
| -56% | -$2.48M |
|
558
Manhattan Associates
MANH
$11.9B
| $2.11M | ﹤0.01% |
71,896
-916
| -1% | -$25.2K |
|
|
DST
559
DELISTED
DST Systems Inc.
DST
| $2.07M | ﹤0.01% |
45,598
-8,998
| -16% | -$382K |
|
560
Provident Financial Services
PFS
$3.14B
| $2.06M | ﹤0.01% |
106,654
+16,676
| +19% | +$307K |
|
|
BDBD
561
DELISTED
BOULDER BRANDS INC
BDBD
| $2.04M | ﹤0.01% |
128,372
-2,129
| -2% | -$33K |
|
|
GTIV
562
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $2.03M | ﹤0.01% |
163,555
-3,413
| -2% | -$41.1K |
|
563
Zions Bancorporation
ZION
$10.1B
| $2.03M | ﹤0.01% |
+67,629
| New | +$1.95M |
|
|
BCPC
564
Balchem Corp
BCPC
$5.26B
| $2.01M | ﹤0.01% |
34,194
-6,563
| -16% | -$371K |
|
565
Glacier Bancorp
GBCI
$6.36B
| $1.97M | ﹤0.01% |
66,078
-148,169
| -69% | -$4.14M |
|
|
FNGN
566
DELISTED
Financial Engines, Inc.
FNGN
| $1.95M | ﹤0.01% |
28,085
+6,408
| +30% | +$394K |
|
567
Blackrock
BLK
$167B
| $1.91M | ﹤0.01% |
6,034
-4,871
| -45% | -$1.45M |
|
|
FL
568
DELISTED
Foot Locker
FL
| $1.86M | ﹤0.01% |
44,977
-9,466
| -17% | -$346K |
|
569
TG Therapeutics
TGTX
$8.19B
| $1.78M | ﹤0.01% |
455,271
-1,083,831
| -70% | -$4.38M |
|
570
Bank of Hawaii
BOH
$3.14B
| $1.71M | ﹤0.01% |
28,990
-886
| -3% | -$51K |
|
571
United Therapeutics
UTHR
$26.1B
| $1.71M | ﹤0.01% |
15,087
-1,040
| -6% | -$93.8K |
|
572
ITT
ITT
$17.1B
| $1.69M | ﹤0.01% |
+38,878
| New | +$1.55M |
|
|
FMER
573
DELISTED
FIRSTMERIT CORP
FMER
| $1.68M | ﹤0.01% |
75,378
+16,457
| +28% | +$370K |
|
574
American States Water
AWR
$3.44B
| $1.67M | ﹤0.01% |
58,056
-1,774
| -3% | -$49.9K |
|
|
N
575
DELISTED
Netsuite Inc
N
| $1.66M | ﹤0.01% |
16,125
-400
| -2% | -$40.1K |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.